top headlines
Resalis Therapeutics has dosed the first participant in a Phase [...]
Hemab Therapeutics has highlighted new clinical and preclinical data across [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Elixirgen Therapeutics has signed an option agreement with Nippon Shinyaku [...]
Adults with epilepsy and hearing loss who use hearing aids [...]
Cereno Scientific has reported encouraging 12-month safety and clinical observations [...]
BioInnovation Institute has opened its first international base in London [...]
The European Commission has granted orphan drug designation to Chiesi [...]
GlobalData has identified Takeda’s oveporexton FDA decision as one of [...]
